Immunohistochemical profiles of claudin-3 in primary and metastatic prostatic adenocarcinoma
2011

Claudin-3 in Prostate Cancer

Sample size: 212 publication Evidence: moderate

Author Information

Author(s): Bartholow Tanner L, Chandran Uma R, Becich Michael J, Parwani Anil V

Primary Institution: University of Pittsburgh School of Medicine

Hypothesis

Can claudin-3 serve as a biomarker for prostate cancer and its metastasis?

Conclusion

Claudin-3 is often overexpressed in prostate cancer, but it does not reliably predict the risk of metastasis.

Supporting Evidence

  • PCa and Mets had the highest absolute staining for claudin-3.
  • Both PCa and Mets had significantly higher staining than BPH and NAC.
  • PIN had a lower, but non-significant, staining score than PCa and Mets.

Takeaway

This study looked at a protein called claudin-3 in prostate cancer samples to see if it could help doctors tell how serious the cancer is. They found that while claudin-3 is usually higher in cancer, it doesn't help predict if the cancer will spread.

Methodology

Immunohistochemistry was used to evaluate claudin-3 expression in tissue microarrays from various prostate tissue types.

Limitations

The study does not provide enough evidence to use claudin-3 as a marker for predicting metastasis risk.

Statistical Information

P-Value

<0.001

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1746-1596-6-12

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication